QualityStocksNewsBreaks – InnerScope Hearing Technologies Inc. (INND) Positioning to Disrupt Global Hearing Device Market

 InnerScope Hearing Technologies (OTC: INND), an emerging and disruptive leader in the direct-to-consumer (“DTC”) hearing technology space, is focused on its goal to provide affordable solutions to the tens of millions of Americans suffering from hearing loss today. “Through its dedicated online portal, www.iHearDirect.com, InnerScope has looked to provide consumers with affordable, Bluetooth app-controlled, self-adjusting hearing technology in a prompt and affordable manner. The company’s HearIQ App for iPhone and Android has been designed to include a free self-checking hearing test, providing billions of people worldwide with the means to detect and self-diagnose early-onset hearing loss. Meanwhile, the company’s proprietary hearing technology provides customers with the ability to personalize each hearing device to their needs in under 10 minutes,” a recent article reads. “InnerScope Hearing Technologies recently acquired HearingAssist, a long-established leader in the direct-to-consumer hearing aid market and Walmart’s largest hearing aid supplier, for a gross consideration of $10 million, with the express intent to create a ‘powerful disruptive company in the global hearing device market.’”

To view the full article, visit https://ibn.fm/8ZCJI

About InnerScope Hearing Technologies Inc.

InnerScope is a leading direct-to-consumer (“DTC”) manufacturer and distributor of FDA-registered hearing aids, hearing assistive devices, hearing health-related products, and personal sound amplifier products (“PSAPs”) (“hearing products”) dedicated to addressing the global demand for affordable hearing solutions. InnerScope’s products and its business model break through the persistent barriers that prevent access to effective hearing solutions. InnerScope’s recent acquisition of iHear Medical Inc., a DTC cloud-based hearing solution provider, gives the company access to over 40 patents and an FDA-registered manufacturing and R&D facility. In addition, InnerScope has acquired HearingAssist, an established leader in the direct-to-consumer hearing aid market with a customer base of over 400,000. These acquisitions, combined with a partnership with Atlazo Inc., a semiconductor innovator for next-generation AI smart devices, will allow InnerScope to take the lead position in the direct-to-consumer hearing solutions market by selling innovated proprietary advanced hearing products through Walmart and other major big box retailers. InnerScope has a full line of hearing products including proprietary, free to the public, automated self-check hearing screening kiosks, which are currently being deployed in some of the nation’s largest retailers and pharmacy chains. For information related to InnerScope Hearing Technologies’ latest hearing aids and related hearing products, please visit www.MyHearIQ.com, www.iHearDirect.com and www.HearingAssist.com. For the most up-to-date information about InnerScope, please visit and follow its official Twitter account @inndstock page: https://twitter.com/inndstock.

NOTE TO INVESTORS: The latest news and updates relating to INND are available in the company’s newsroom at https://ibn.fm/INND

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

Nowigence Inc.’s Pluaris Offers Solution for Wide Range of Users, Needs

 

• Pluaris automates reading and analysis of textual data
• The app puts the power of data science into the hands of a wide range of consumers
• The platform is designed to help users who need to learn the most in the least amount of time

Knowledge workers, lifelong learners and teams and enterprises all stand to benefit from Nowigence’s focus on simplifying the challenges of learning. Recognizing the increasing demand for a quick, accessible solution to the overwhelming amount of information available in today’s world, the company created Pluaris(TM). The cloud-based app automates reading and analysis of textual data so users can learn more in less time, uncover hidden insights, and stay on top of the information they need to know. 

Pluaris integrates state-of-the-art data-processing techniques in an intuitive interface that puts the power of data science into the hands of a wide range of consumers. Nowigence has shared several user-success stories, showing the app’s diverse power and appeal (https://ibn.fm/PMScd). For knowledge workers who need to learn the most in the least amount of time, Pluaris automatically retrieves and analyzes publicly available reports, news and analysis on selected topics of interest every day. Users can then scroll through an annotated news feed on their phones, tablets or laptop whenever it is most convenient. 

“A Pluaris enterprise customer was interested in tracking news and events in the telecom industry,” the company reported. “The customer was able to quickly create and then fine-tune a list of topics to monitor. In just two days, she had an annotated news feed covering the telecom industry available for her whole team.”

Another customer was already using Pluaris for business reasons when he decided to focus on improving his health, so he turned to Pluaris on a personal level. He uploaded research reports to Pluaris, read through the summaries and explored the annotated labels. He then set up Pluaris to monitor topics such as “lowering fasting blood sugar” and “low glycemic food.” The company reported that from those results, the Pluaris user built an action list of daily habits for diet and fitness and, within a couple months, brought his fasting blood sugar level down.

As for enterprise users, Nowigence shared the instance of a Pluaris user at one of the world’s largest aluminum-mining companies whose manager had assigned her to prepare talking points for an upcoming investor meeting. “Using Pluaris, she had over time built a database of documents, including transcripts, notes, Q&A sessions, speeches and internal documents, some of which were from previous investor meetings,” the company stated. “She was able to quickly explore that knowledge base through the Pluaris Dashboard, drilling down using various filters. She quickly pulled this information together in a Pluaris Notebook and shared the note directly with her boss.”

The ways to use Pluaris are almost unlimited, and the SaaS platform is flexible, accessible and affordable. 

For more information, visit the company’s website at www.Nowigence.com.

NOTE TO INVESTORS: The latest news and updates relating to Nowigence are available in the company’s newsroom at https://ibn.fm/NOW

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – BevCanna Enterprises Inc.’s (CSE: BEV) (OTCQB: BVNNF) (FSE:7BC) Leadership Position Recognized in Food and Beverage, Cannabis Products Categories

 BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC), a diversified health and wellness beverage and natural products company, recently announced it had been named as one of the 101 Top Food and Beverage Startups and Companies in Canada by Best Startup Canada. In addition, BevCanna was also recognized as one of the Top 101 Cannabis Startups and Companies in Canada, among innovators and growth companies within the Canadian cannabis industry. A recent article quotes BevCanna CEO Marcello Leone as saying, “This recognition of our leadership position within both the food and beverage and the cannabis products categories validates our strategy of developing innovative, highly customized beverage products that appeal to a range of target markets, including value, craft and premium positioning, for both our in-house brands and our white-label clients.” BevCanna Enterprises’ recent accolades come amid a period of ongoing growth momentum for the company, most aptly illustrated through its strong third-quarter earnings report. In addition, its commercial prospects have also gone from strength to strength as the company worked toward broadening its product portfolio.

To view the full article, visit https://ibn.fm/Hj7Ne

About BevCanna Enterprises Inc.

BevCanna Enterprises is a diversified health and wellness beverage and natural products company. BevCanna develops and manufactures a range of alkaline, plant-based and cannabinoid beverages and supplements for both in-house brands and white-label clients. With decades of experience creating, manufacturing and distributing iconic brands that resonate with consumers on a global scale, the team demonstrates an expertise unmatched in the nutraceutical and cannabis-infused beverage categories. Based in British Columbia, Canada, BevCanna owns a pristine alkaline spring water aquifer and a world–class 40,000–square–foot, HACCP-certified manufacturing facility, with a bottling capacity of up to 210M bottles annually. BevCanna’s extensive distribution network includes more than 3,000 points of retail distribution through its market-leading TRACE brand, its Pure Therapy natural health and wellness e-commerce platform, its fully licensed Canadian cannabis manufacturing and distribution network, and a partnership with top U.S. cannabis beverage company Keef Brands. For more information about the company, visit www.BevCanna.com.

NOTE TO INVESTORS: The latest news and updates relating to BVNNF are available in the company’s newsroom at http://ibn.fm/BVNNF 

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – SPYR Inc. (SPYR) Affiliate Unveils MagixBlock USB DataBlocker as Standalone Offering

 SPYR (OTCQB: SPYR), dba SPYR Technologies, a technology company, and its subsidiary, Applied Magix Inc., has made its MagixBlock USB DataBlocker product a standalone option. Applied Magix develops and resells Apple(R) ecosystem-compatible products specifically for IoT smart home and connected car markets. The MagixBlock USB DataBlocker product combines both USB-A and USB-C versions in a universal package. “While our customers primarily use the MagixBlock DataBlocker to prevent their car’s not-so-smart system from interfering with MagixDrive operations, many have asked to have MagixBlock made available separately,” said Applied Magix CEO Dr. Harald Zink in the press release. “This way our customers can use our exemplary product to protect their iOS devices while traveling.”

To view the full press release, visit https://ibn.fm/j51cf  

About SPYR Inc.

SPYR Technologies is a technology company that, through its subsidiary Applied Magix Inc., develops and resells Apple ecosystem-compatible products with an emphasis on the growing multibillion-dollar IoT smart home and connected car markets. SPYR continues to identify and target acquisitions that will grow its footprint in the industry and expand the products it offers consumers, including companies developing artificial intelligence (“AI”) and smart-technology products. For more information about this company, visit www.SPRY.com.

NOTE TO INVESTORS: The latest news and updates relating to SPYR are available in the company’s newsroom at https://ibn.fm/SPYR

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

InMed Pharmaceuticals Inc.’s (NASDAQ: INM) Recent Access of Manufacturing Technologies Now Give It the Potential to Synthetically Produce Rare Cannabinoids at Large Scale, a Unique and Coveted Position in the Rapidly Developing Rare Cannabinoid Space

 

• Rare cannabinoids are cannabinoid compounds other than CBD and THC which are not yet produced in large scale but which have potentially greater benefits
• InMed acquired BayMedica in October 2021, bringing on board unmatched expertise in large-scale bio-production technologies applicable to rare cannabinoids
• As a result of this acquisition, InMed, already a leader in the production of rare cannabinoid CBC, is now in the unique and highly desired position to undertake large-scale production of other rare cannabinoids, with applications as wide as the current CBD market
• The company plans to launch new rare cannabinoid products in the first half of 2022

The human body naturally produces cannabinoids – endocannabinoids such as anandamide (“ANA”) – as part of a physiologic system that maintains human health by reducing inflammation and promoting homeostasis (https://ibn.fm/TavdM). So named after the plant that led to its discovery, the endocannabinoid system (“ECS”) however only produces two known cannabinoid compounds, while over 140 variants can be found in the cannabis plant, most in trace amounts. 

Of the latter group of cannabinoids, cannabidiol (“CBD”) and tetrahydrocannabinol (“THC”) are the most common. Researchers have in fact studied both of them for decades, with studies showing that THC is the primary active ingredient in cannabis, followed by CBD. 

“Although CBD and THC make up most of the content in cannabis plants, they are not the only compounds that matter. The plants also have many rare cannabinoids with potential health and manufacturing uses that can now be studied,” a 2021 Forbes article reads (https://ibn.fm/J50nM).

Studies now suggest that these “rare cannabinoids” could offer more potent medical benefits than CBD and without the psychoactive attribute of THC, representing a huge market. However, unlike the abundant THC and CBD products already covering the marketplace, rare cannabinoids are extremely difficult to extract from the cannabis plant and have therefore not been looked at more closely to ascertain their medical benefits. 

In understanding the immense potential of rare cannabinoids, InMed Pharmaceuticals (NASDAQ: INM), a clinical-stage company developing a pipeline of cannabinoid-based pharmaceutical drug candidates as well as manufacturing and delivering high-quality rare cannabinoids for a variety of uses, sees these rare cannabinoids as having applications as wide as CBD and THC. This is a hot topic in the industry. However, the industry-wide problem has always been to obtain the production scales necessary for cost-effective commercialization of such compounds, while also ensuring the purity and consistency that can be difficult at even low volumes. 

The answer is to develop and apply successful large-scale bio-synthesis capabilities, technologies that are complex and not readily available for these rare compounds. 

In October, the company celebrated a huge milestone that cemented its status as a leader in this rapidly developing field. It completed the acquisition of Bay Medica, a U.S.-based private company that specializes in the development of large-scale manufacturing and commercialization of rare cannabinoids (https://ibn.fm/RZaFE). The company has amassed an unmatched talent pool of large-scale synthetic production expertise from the industry that can be applied to rare cannabinoids.

The acquisition complements InMed’s efforts within the pharmaceutical industry by adding BayMedica’s synthetic biology and chemical synthesis capabilities and expertise, in what would provide InMed with complete rare cannabinoid manufacturing flexibility to select the most appropriate, cost-effective method based on the target cannabinoid and applicable quality specifications for the desired industry.

“[BayMedica has] been deploying different manufacturing techniques such as chemical synthesis, yeast biosynthesis, and InMed has not only bacterial biosynthesis but also a new approach called enzymatic biotransformation – our IntegraSyn(TM) system,” stated InMed CEO Eric A. Adams during the 2022 Edison Open House Global Healthcare Conference held on January 25 (https://ibn.fm/cLV9z).

“I think we are the only company out there that can offer a full slate of these different manufacturing technologies. That’s important because no one technology is best for the whole spectrum of different cannabinoids… So, we are now in a unique position to pick and choose whatever the lowest cost manufacturing technology is for any one of these different cannabinoids,” added Adams.

InMed believes it is currently the leader in large batch production of the rare cannabinoid cannabichromene (“CBC”) and is confident it can apply this manufacturing technology to create, at a larger scale, key rare cannabinoids, such as cannabidivarin (“CBDV”) and tetrahydrocannabivarin (“THCV”), on which it is currently focusing its attention. Earlier this year, InMed announced the launch of the rare cannabinoid cannabicitran (“CBT”) into the health and wellness sector, marking the first of several new product launches planned for the first half of 2022 (https://ibn.fm/idE7P).

For more information, visit the company’s website at www.InMedPharma.com.

NOTE TO INVESTORS: The latest news and updates relating to INM are available in the company’s newsroom at https://ibn.fm/INM

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – GreenBox POS (NASDAQ: GBOX) to Present at Winter Wonderland – Best Ideas Virtual Investor Conference

 GreenBox (NASDAQ: GBOX), an emerging and rapidly growing fintech company, today announced that management will present at the Winter Wonderland Virtual Conference — Best Ideas from the Buyside, which is slated to take place from Feb. 8-11, 2022. Chairman Ben Errez will host a virtual presentation and participate in one-on-one meetings throughout the event. Errez’s presentation is scheduled to begin at 4 p.m. ET on Tuesday, Feb. 8, at which time he will discuss GreenBox’s rapidly expanding blockchain based payment processing business, its upcoming stablecoin spin-off and its strategy to play an integral role in the digital payments landscape. Interested parties should visit https://ibn.fm/V0Pnf to register for the event and access a live audio webcast and archive of the presentation.

To view the full press release, visit https://ibn.fm/XRJ9X

About GreenBox POS

GreenBox is an emerging financial technology company leveraging proprietary blockchain security to build customized payment solutions. The company’s applications enable an end-to-end suite of turnkey financial products, fraud detection and improving the efficiency of handling large-scale commercial processing volumes for its merchant clients globally. For more information, please visit the company’s website at www.GreenBoxPOS.com.

NOTE TO INVESTORS: The latest news and updates relating to GBOX are available in the company’s newsroom at https://ibn.fm/GBOX

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – Clearmind Medicine Inc. (CSE: CMND) (FSE: CWY0) (OTC: CMNDF) to Host Third Event in Psychedelics for Alcoholism Series

 Clearmind Medicine (CSE: CMND) (FSE: CWY0) (OTC: CMNDF) a psychedelic drug company, has announced the speaker for the third webinar in its Psychedelics for Alcoholism series. The company has invited addiction specialist and world-renowned author Dr. Gabor Maté to talk on the effects of Alcohol Use Disorder, addition and trauma. The webinar will also include information about Clearmind’s patented portfolio as an effective treatment for the disorder. A retired Vancouver physician and a member of the Order of Canada, Maté has written several books with his most recent book —  “The Myth of Normal: Trauma, Illness and Healing in a Toxic Culture” — scheduled for publication this year. Other participants in the webinar include Clearmind CEO Adi Zuloff-Shani and Clearmind vice president of business development Mark Haden.

To attend the webinar, visit https://ibn.fm/Hkzcp

To view more information,  visit https://ibn.fm/XDk3T

About Clearmind Medicine Inc.

Clearmind is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods or supplements. The company’s intellectual portfolio currently consists of four patent families. Clearmind intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio. For more information about the company, visit www.ClearmindMedicine.com.

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php